Key Finding
Acupuncture achieved a 57.9% composite response rate for IBS-D symptoms compared to 41.4% with sham treatment, with benefits sustained over 18 weeks and no serious adverse events.
A new study from China offers promising news for people suffering from irritable bowel syndrome with diarrhea (IBS-D). Researchers tested whether acupuncture could help reduce the uncomfortable symptoms that affect roughly 4% of adults and often persist despite standard treatments.
The study involved 280 patients across six hospitals who were randomly assigned to receive either real acupuncture or sham acupuncture (using blunt-tipped needles at non-treatment points). Both groups received 15 treatment sessions over six weeks, then were followed for an additional 12 weeks.
The results were significant. After six weeks, nearly 58% of patients receiving real acupuncture experienced meaningful improvement—defined as at least 30% reduction in abdominal pain and 50% fewer days with diarrhea—compared to 41% in the sham group. The benefits started appearing by week three and lasted throughout the 18-week study period, with only one brief exception at week 16.
Importantly, no serious side effects were reported, suggesting acupuncture is a safe option for IBS-D. Patients experienced improvements in both pain levels and stool consistency, two of the most troublesome symptoms of this condition.
For the millions who continue experiencing IBS-D symptoms despite trying dietary changes, fiber supplements, and medications, this study suggests acupuncture could be a valuable alternative or complementary treatment. The sustained benefits lasting several months after treatment is particularly encouraging, as IBS is typically a chronic condition requiring long-term management.
If you're considering acupuncture for IBS-D, seek out a licensed acupuncturist with experience treating digestive disorders.
This multicenter RCT from six Chinese hospitals evaluated acupuncture efficacy for diarrhea-predominant IBS (IBS-D) using Rome IV diagnostic criteria. 280 patients aged 18-75 were randomized 1:1 to receive 15 sessions of acupuncture versus sham acupuncture (blunt-tipped needles at non-acupoints) over six weeks, with 12-week follow-up.
The primary composite endpoint—≥30% improvement in worst abdominal pain plus ≥50% reduction in diarrhea days at week 6—was achieved by 57.9% of acupuncture patients versus 41.4% of controls (RR 1.40; P=0.008). Between-group differences emerged at week 3 and persisted through week 18, except at week 16. Secondary outcomes showed improvements in both abdominal pain and stool consistency. No severe adverse events occurred.
Clinical significance: This rigorously designed trial demonstrates acupuncture provides clinically meaningful, sustained benefit for IBS-D patients who often remain symptomatic with conventional therapies. The sustained efficacy beyond treatment cessation supports acupuncture as a viable therapeutic option for IBS-D management.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 A 12-week randomized controlled trial is underway to evaluate whether transcutaneous auricular vagus nerve stimulation (taVNS) can reduce body weight in patients with obesity by modulating the microbiota-gut-brain axis, assessed through fMRI, gut microbiota profiling, and serum brain-gut peptides.
📌 Acupuncture significantly reduced chronic urticaria activity scores and improved dermatology-related quality of life compared to sham acupuncture and waitlist control, performing comparably to Western medicine for symptom control.
📌 77.6% of women with moderate-to-severe menopausal symptoms experienced a clinically relevant reduction in symptoms following a standardized acupuncture protocol, with vocational education level being the most consistent predictor of treatment response.